India, Nov. 25 -- Cancer diagnosis startup Morphle Labs has raised $5 Mn (about INR 44.6 Cr) in its Series A funding round from Inflexor Ventures to enhance tech capabilities and expand global footprint.

The Bengaluru-based company, which also has operations in the US, is planning to deploy the freshly raised capital in scaling manufacturing for its flagship products RoboTome and MorphoLens. Additionally, the startup is also mulling to secure regulatory approvals and talent acquisition across engineering and research teams.

Founded in 2017 by Rohit Hiwale and Anchit Navelkar, Morphle Labs leverages robotics, precision hardware, optics, and AI to build advanced technologies for automating tissue diagnostics.

The company claims to have f...